Deepa Venkataraman

Deepa Venkataraman is an accomplished pharmaceutical executive with extensive experience in patient safety, pharmacovigilance, and quality assurance. Currently serving as Vice President and Head of Global Patient Safety and Pharmacovigilance at Corcept Therapeutics, Deepa oversees the safety of development compounds and marketed products. Previous roles include Senior Vice President at Summit Therapeutics, where responsibilities encompassed patient safety and quality assurance, and various leadership positions at AbbVie and Pharmacyclics, focused on global case management and pharmacovigilance. Deepa's career also includes foundational roles in drug safety operations at Johnson & Johnson and Quintiles, as well as research and teaching positions in pharmacology and medicinal chemistry. Deepa holds advanced degrees in medical aspects of adverse drug reactions and pharmaceutical medicinal chemistry.